Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metalytics develops predictive digital twin technologies and proprietary metabolic flux analysis platforms that enable biopharmaceutical and biotechnology companies to optimize cell line development, media design, and manufacturing processes. Their solutions reduce experimental effort, cost of goods, and time-to-market by providing actionable insights into cellular metabolism using AI-driven analytics. The company’s tools are used globally by leading life science organizations to improve productivity and product quality in biologics manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metalytics.